Pure Global

Dengue IgG/IgM Rapid Test - India CDSCO Medical Device Registration

Dengue IgG/IgM Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000081_1b7c799a223f84d606c111737f26e671_96caab84818e264c4e74964b131f08c4. This device is marketed under the brand name TRURAPID® RESIST CTX-M Rapid Test. The license holder is KILPEST INDIA LIMITED, and it is classified as Device Class Class B. The approving authority is Madhya Pradesh.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Dengue IgG/IgM Rapid Test
UID: MFG/IVD/2023/000081_1b7c799a223f84d606c111737f26e671_96caab84818e264c4e74964b131f08c4

Brand Name

TRURAPID® RESIST CTX-M Rapid Test

License Holder

KILPEST INDIA LIMITED

Device Class

Class B

Approving Authority

Madhya Pradesh

Product Information

Dengue Antibody test reagent/kit is a medical device intended for the detection of Dengue Antibody in blood/body fluids. TRURAPID® Dengue IgG/IgM Test is an immune-chromatographic assay designed for the qualitative detection and differentiation of specific IgM and IgG antibodies to dengue virus in human whole blood, serum, or plasma. It is intended to be used as in-vitro diagnostic of dengue fever. The test can be used for the presumptive distinction between a primary and secondary dengue infection. The results obtained should not be the sole determinant for clinical decisions. Test should be performed by trained personnel who have received the required training for rapid test.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing